Copy to clipboard 
Mathys, an Enovis company, released two further implant sizes in its flagship RM Pressfit vitamys cup range. To coincide with this, Mathys is releasing a full range of hooded RM Pressfit vitamys implants plus an entirely new modular instrument set. All will be available in July 2022.
Employing an equatorial press-fit design, the RM cup design supports physiological load distribution across the acetabular side of the hip joint. Key properties include elasticity, an osteoinductive titanium particle coating and a thick polyethylene wall.
The RM Pressfit vitamys cup features a bearing surface comprising a vitamin E-enriched, highly crosslinked polyethylene. The interaction of this isoelastic polyethylene with maximal wall thickness and an outer titanium particle coating is designed to reduce the risk of osteolysis and preserve surrounding bone.
The RM Pressfit vitamys cup has a similar elasticity as the surrounding bone. This impacts stress-shielding behavior positively, preventing potential reduction in bone density.
The RM Pressfit vitamys cup addresses key clinical challenges for implant survival, namely long-term implant stability and the preservation of bone stock in the short-, medium- and long-term, while reducing the risk of wear-induced osteolysis.
Further, Mathys is augmenting its flagship cup series with two additional small implant sizes (42/28 and 46/32) for the current RM Pressfit vitamys portfolio, as well as a complete range of hooded RM Pressfit vitamys implants. The additional range of hooded RM Pressfit cups is specifically intended to serve clinicians who prefer a posterior approach.
This series enhancement will be released with a completely new modular instrument set. The set has been designed to further optimize workflow efficiency, and it offers various options for customized configurations in Mathys’ markets.
Source: Mathys
Mathys, an Enovis company, released two further implant sizes in its flagship RM Pressfit vitamys cup range. To coincide with this, Mathys is releasing a full range of hooded RM Pressfit vitamys implants plus an entirely new modular instrument set. All will be available in July 2022.
Employing an equatorial press-fit design, the RM cup...
Mathys, an Enovis company, released two further implant sizes in its flagship RM Pressfit vitamys cup range. To coincide with this, Mathys is releasing a full range of hooded RM Pressfit vitamys implants plus an entirely new modular instrument set. All will be available in July 2022.
Employing an equatorial press-fit design, the RM cup design supports physiological load distribution across the acetabular side of the hip joint. Key properties include elasticity, an osteoinductive titanium particle coating and a thick polyethylene wall.
The RM Pressfit vitamys cup features a bearing surface comprising a vitamin E-enriched, highly crosslinked polyethylene. The interaction of this isoelastic polyethylene with maximal wall thickness and an outer titanium particle coating is designed to reduce the risk of osteolysis and preserve surrounding bone.
The RM Pressfit vitamys cup has a similar elasticity as the surrounding bone. This impacts stress-shielding behavior positively, preventing potential reduction in bone density.
The RM Pressfit vitamys cup addresses key clinical challenges for implant survival, namely long-term implant stability and the preservation of bone stock in the short-, medium- and long-term, while reducing the risk of wear-induced osteolysis.
Further, Mathys is augmenting its flagship cup series with two additional small implant sizes (42/28 and 46/32) for the current RM Pressfit vitamys portfolio, as well as a complete range of hooded RM Pressfit vitamys implants. The additional range of hooded RM Pressfit cups is specifically intended to serve clinicians who prefer a posterior approach.
This series enhancement will be released with a completely new modular instrument set. The set has been designed to further optimize workflow efficiency, and it offers various options for customized configurations in Mathys’ markets.
Source: Mathys
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
